With that in mind, we focus on developing lasting, well-aligned partnerships with exceptional entrepreneurs and executives to build valuable companies. In addition to capital, we provide deep healthcare domain expertise and an extensive network of industry contacts and resources.

Learn More
News
March 17, 2017 Threshold Pharmaceuticals and Molecular Templates Agree to Combine
Read More
March 6, 2017 FDA Advisory Committee Strongly Supports Granting De Novo Application for Claret TAVR Cerebral Protection System
Read More